THYGENEXT Trademark

Trademark Overview

On Monday, April 9, 2018, a trademark application was filed for THYGENEXT with the United States Patent and Trademark Office. The USPTO has given the THYGENEXT trademark a serial number of 87868479. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, May 30, 2025. This trademark is owned by Interpace Diagnostics, LLC. The THYGENEXT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Human biomedical molecular diagnostic testing, monitoring and reporting services to aid in the diagnosis and resolution of thyroid cancer
thygenext

General Information

Serial Number87868479
Word MarkTHYGENEXT
Filing DateMonday, April 9, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, May 30, 2025
Registration Number5651597
Registration DateTuesday, January 8, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2018

Trademark Statements

Pseudo MarkTHYROID GEN NEXT
Goods and ServicesHuman biomedical molecular diagnostic testing, monitoring and reporting services to aid in the diagnosis and resolution of thyroid cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 17, 2018
Primary Code044
First Use Anywhere DateSunday, July 1, 2018
First Use In Commerce DateSunday, July 1, 2018

Trademark Owner History

Party NameInterpace Diagnostics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameInterpace Diagnostics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameInterpace Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Thursday, April 12, 2018NEW APPLICATION ENTERED
Tuesday, April 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 26, 2018ASSIGNED TO EXAMINER
Friday, July 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 15, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 4, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 5, 2018TEAS STATEMENT OF USE RECEIVED
Monday, November 5, 2018USE AMENDMENT FILED
Monday, November 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 28, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, November 30, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, December 1, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 8, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, February 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 8, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 8, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 8, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, May 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 30, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 30, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

thygenext diagnosis services resolution thyroid cancer reporting monitoring biomedical molecular diagnostic